Stockscreener 앱 받기
3.94
12.57%
0.44
시간 외 거래:
4.05
0.11
+2.79%
전일 마감가:
$3.50
열려 있는:
$3.5
하루 거래량:
85,019
Relative Volume:
0.26
시가총액:
$14.62M
수익:
-
순이익/손실:
$-16.60M
주가수익비율:
-4.427
EPS:
-0.89
순현금흐름:
$-23.48M
1주 성능:
-0.76%
1개월 성능:
+23.90%
6개월 성능:
-73.31%
1년 성능:
-90.59%
1일 변동 폭
$3.34
$3.94
1주일 범위
$3.34
$3.94
52주 변동 폭
$3.09
$44.25
Briacell Therapeutics Corp Stock (BCTX) Company Profile
명칭
Briacell Therapeutics Corp
전화
(604) 921-1810
주소
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER
BCTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BCTX
Briacell Therapeutics Corp
|
3.94 | 14.62M | 0 | -16.60M | -23.48M | -0.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.62 | 121.88B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.45 | 62.69B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
555.11 | 33.86B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
235.74 | 30.51B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
238.51 | 25.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Briacell Therapeutics Corp Stock (BCTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-02-14 | 개시 | H.C. Wainwright | Buy |
Briacell Therapeutics Corp 주식(BCTX)의 최신 뉴스
Virtu Financial LLC Makes New $27,000 Investment in BriaCell Therapeutics Corp. (NASDAQ:BCTX) - Defense World
BriaCell Therapeutics (OTCMKTS:BCTXF) Shares Up 4% – Here’s What Happened - Defense World
BriaCell Therapeutics (NASDAQ:BCTX) Trading 4% Higher – Time to Buy? - Defense World
(BCT) Technical Patterns and Signals (BCT:CA) - news.stocktradersdaily.com
BriaCell Therapeutics: Stocks Undervalued by Analyst Consensus on TSX (BCT) - The Globe and Mail
BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Short Interest Update - Defense World
BriaCell to Present Clinical and Preclinical Data at the 2025 AACR Conference - GlobeNewswire
BriaCell to Showcase Cancer Immunotherapy Advances at AACR 2025 - TipRanks
New Clinical Data: BriaCell's Registration Trial Results for Advanced Breast Cancer Treatment - Stock Titan
Where Will Rigetti Computing Stock Be in 1 Year? - The Globe and Mail
Dan Ives Is Pounding the Table on Microsoft Stock. Should You Buy the Dip? - The Globe and Mail
Quantum Gamble? Is IonQ's Stock an Opportunity or a Mirage? - The Globe and Mail
(BCT) Stock Evaluation Report (BCT:CA) - Stock Traders Daily
(BCT) Market Dynamics and Trading Signals (BCT:CA) - news.stocktradersdaily.com
What To Expect From Carnival’s (CCL) Q1 Earnings - The Globe and Mail
BriaCell’s Phase 3 Breast Cancer Trial Proceeds After Safety Review By Investing.com - Investing.com South Africa
Stocks In Play: BriaCell Therapeutics Corp By Baystreet.ca - Investing.com Canada
(BCT) Technical Analysis and Trading Signals (BCT:CA) - Stock Traders Daily
BriaCell Therapeutics Corp - Baystreet.ca
Stocks in play: BriaCell Therapeutics Corp - The Globe and Mail
BriaCell Therapeutics Says Data Safety Monitoring Board Recommends Continuation of Phase 3 Trial in Metastatic Breast Cancer - MarketScreener
BriaCell’s Phase 3 Metastatic Breast Cancer Study Receives Positive DSMB Review - TipRanks
BriaCell’s Phase 3 Breast Cancer Trial Proceeds After Safety Review - Investing.com
Second Data Safety Monitoring Board Issues Positive - GlobeNewswire
Major Milestone: BriaCell's Breast Cancer Immunotherapy Passes Critical Safety Review in Phase 3 Trial - Stock Titan
3 Reasons DRS is Risky and 1 Stock to Buy Instead - The Globe and Mail
Briacell Therapeutics Corp reports results for the quarter ended January 31Earnings Summary - TradingView
BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Sees Significant Growth in Short Interest - Defense World
Briacell Therapeutics Corp expected to post a loss of $1.12 a shareEarnings Preview - TradingView
3 Industrials Stocks Walking a Fine Line - The Globe and Mail
BriaCell Therapeutics (OTCMKTS:BCTXF) Trading 0.3% Higher – Here’s Why - Defense World
BriaCell Therapeutics Reports Continued Financial Challenges - TipRanks
BriaCell subsidiary reports interim financial results By Investing.com - Investing.com Australia
BriaCell Therapeutics Corp. SEC 10-Q Report - TradingView
BriaCell subsidiary reports interim financial results - Investing.com India
BriaCell Therapeutics (BCTX) Projected to Post Quarterly Earnings on Monday - Defense World
BriaCell Therapeutics: Top 10 Undervalued Healthcare Sector Stocks on TSX (BCT) - The Globe and Mail
BCTX stock touches 52-week low at $3.31 amid sharp annual decline By Investing.com - Investing.com South Africa
BCTX stock touches 52-week low at $3.31 amid sharp annual decline - Investing.com
BriaCell Therapeutics Corp. (NASDAQ:BCTX) Sees Significant Increase in Short Interest - Defense World
BriaCell Therapeutics (NASDAQ:BCTX) versus Actinium Pharmaceuticals (NYSE:ATNM) Critical Analysis - Defense World
Dye & Durham Limited - Baystreet.ca
(BCT) Equity Trading Insights (BCT:CA) - Stock Traders Daily
(BCT) Market Performance Analysis (BCT:CA) - Stock Traders Daily
BriaCell Therapeutics Corp (NASDAQ: BCTX) – An Analysis Is What You Need - Stocks Register
(BCT) Investment Analysis (BCT:CA) - Stock Traders Daily
(BCT) Trading Advice (BCT:CA) - Stock Traders Daily
BriaCell Therapeutics: A Biotech Stock on the Brink of a Turnaround? - HPBL
Biotechs on the Brink: 2 Stocks With Huge Potential - MarketBeat
BriaCell regains Nasdaq compliance with bid price By Investing.com - Investing.com Australia
Briacell Therapeutics Corp (BCTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.01%
자본화:
|
볼륨(24시간):